STOCK TITAN
  1. Home
  2. Sec-filings
  3. EGAN
  4. [Form 4] EGAIN Corp Insider Trading Activity

Form 4: 500 EGAN shares via option exercise; 3,000 held, 0 options left

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

eGain (EGAN) reported an insider transaction by director Phiroz P. Darukhanavala. On 10/28/2025, he exercised stock options (transaction code M) for 500 shares of common stock at $4.335 per share. Following the transaction, he beneficially owns 3,000 shares directly.

The exercised option covered 500 underlying shares and now shows 0 derivative securities remaining. The option was fully vested on 11/06/2016 and carried an expiration date of 11/06/2025.

Positive

  • None.

Negative

  • None.
Insider Darukhanavala Phiroz P
Role Director
Type Security Shares Price Value
Exercise Stock Option (right to buy) 500 $0.00 --
Exercise Common Stock 500 $4.335 $2K
Holdings After Transaction: Stock Option (right to buy) — 0 shares (Direct); Common Stock — 3,000 shares (Direct)
Footnotes (1)
  1. [object Object]
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Darukhanavala Phiroz P
(Last) (First) (Middle)
1252 BORREGAS AVENUE
(Street)
SUNNYVALE CA 94089
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
EGAIN Corp [ EGAN ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/28/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/28/2025 M 500 A $4.335 3,000 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $4.335 10/28/2025 M 500 (1) 11/06/2025 Common Stock 500 $0 0 D
Explanation of Responses:
1. The options, representing a right to purchase a total of 500 shares, became fully vested on November 6, 2016.
/s/ Phiroz P. Darukhanavala 10/30/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did EGAN disclose in this Form 4?

A director exercised stock options for 500 shares at $4.335 on 10/28/2025 and now holds 3,000 common shares directly.

Who is the reporting person in EGAN’s Form 4?

Director Phiroz P. Darukhanavala is the reporting person.

How many EGAN shares were acquired and at what price?

The filing shows 500 shares acquired upon option exercise at $4.335 per share.

What are the director’s EGAN holdings after the transaction?

Beneficial ownership is 3,000 shares, held directly.

What happened to the derivative securities (options)?

After exercising, the report shows 0 derivative securities remaining from this option grant.

When did the options vest and expire?

They became fully vested on 11/06/2016 with an expiration date of 11/06/2025.